Nyrada Inc – Collaboration with World-class Teams at Walter Reed & UNSW Extended to 2025

• Collaboration with the Walter Reed Army Institute of Research (WRAIR) and UNSW
Sydney (UNSW) extended from February 2023 through to January 2025
• World-leading scientific teams to evaluate the efficacy of Nyrada’s brain injury drug
candidate to reduce secondary brain damage following a traumatic brain injury (TBI)
• ~5.5 million people suffer a severe TBI each year1, making TBI a serious and lifethreatening
condition with significant unmet clinical need
• Collaboration aligns with WRAIR’s mission to develop ground-breaking solutions to
mitigate the impact of TBIs which affect 1 in 25 US military service members